Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

2.

Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S.

J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31. doi: 10.1097/chi.0b013e31815a56f1. Review.

PMID:
18174822
3.

The potential for misuse and abuse of medications in ADHD: a review.

Clemow DB, Walker DJ.

Postgrad Med. 2014 Sep;126(5):64-81. doi: 10.3810/pgm.2014.09.2801. Review.

PMID:
25295651
4.
5.

ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.

Kollins SH.

J Atten Disord. 2008 Sep;12(2):115-25. doi: 10.1177/1087054707311654. Epub 2008 Jan 11. Review.

PMID:
18192623
6.

Misuse of Methylphenidate.

Clemow DB.

Curr Top Behav Neurosci. 2017;34:99-124. doi: 10.1007/7854_2015_426. Review.

PMID:
26695166
7.

Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.

Eiland LS, Bell EA, Erramouspe J.

Ann Pharmacother. 2014 Oct;48(10):1350-5. doi: 10.1177/1060028014541791. Epub 2014 Jun 30. Review.

PMID:
24982313
8.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
9.

ADHD and the rise in stimulant use among children.

Mayes R, Bagwell C, Erkulwater J.

Harv Rev Psychiatry. 2008;16(3):151-66. doi: 10.1080/10673220802167782. Review.

PMID:
18569037
10.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
11.

Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.

Simon N, Rolland B, Karila L.

Curr Pharm Des. 2015;21(23):3359-66. Review.

PMID:
26088112
12.

Recent Trends in Stimulant Usage.

Safer DJ.

J Atten Disord. 2016 Jun;20(6):471-7. doi: 10.1177/1087054715605915. Epub 2015 Oct 20. Review.

PMID:
26486603
14.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
15.

Stimulant therapy in attention deficit/hyperactivity disorder.

Baldwin RL.

J Ark Med Soc. 2003 Dec;100(6):203-6. Review.

PMID:
14661403
16.

[Methylphenidate misuse].

Bruggisser M, Bodmer M, Liechti ME.

Praxis (Bern 1994). 2012 Feb 29;101(5):299-305. doi: 10.1024/1661-8157/a000856. Review. German.

PMID:
22377977
17.

Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).

Kollins SH.

Am J Addict. 2007;16 Suppl 1:35-42; quiz 43-4. Review.

PMID:
17453605
18.

Stimulant prescription cautions: addressing misuse, diversion and malingering.

Rabiner DL.

Curr Psychiatry Rep. 2013 Jul;15(7):375. doi: 10.1007/s11920-013-0375-2. Review.

PMID:
23712725
19.

Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences.

Bogle KE, Smith BH.

Curr Drug Abuse Rev. 2009 May;2(2):157-76. Review.

PMID:
19630746
20.

Supplemental Content

Support Center